$356 Million is the total value of Affinity Asset Advisors, LLC's 81 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | APOGEE THERAPEUTICS INC | $22,260,843 | – | 1,045,110 | +100.0% | 6.26% | – | |
| CRNX | New | CRINETICS PHARMACEUTICALS IN | $13,383,000 | – | 450,000 | +100.0% | 3.76% | – |
| TEVA | New | TEVA PHARMACEUTICAL INDS LTDcall | $11,220,000 | – | 1,100,000 | +100.0% | 3.16% | – |
| ARKG | New | ARK ETF TRput | $6,965,000 | – | 250,000 | +100.0% | 1.96% | – |
| ESTA | New | ESTABLISHMENT LABS HLDGS INCcall | $6,869,800 | – | 140,000 | +100.0% | 1.93% | – |
| KRYS | New | KRYSTAL BIOTECH INC | $6,670,000 | – | 57,500 | +100.0% | 1.88% | – |
| ALKS | New | ALKERMES PLCcall | $5,602,000 | – | 200,000 | +100.0% | 1.58% | – |
| APLS | New | APELLIS PHARMACEUTICALS INCput | $4,945,200 | – | 130,000 | +100.0% | 1.39% | – |
| IMVT | New | IMMUNOVANT INCput | $4,917,759 | – | 128,100 | +100.0% | 1.38% | – |
| SVRA | New | SAVARA INC | $4,347,000 | – | 1,150,000 | +100.0% | 1.22% | – |
| New | TANGO THERAPEUTICS INC | $3,941,000 | – | 350,000 | +100.0% | 1.11% | – | |
| MRSN | New | MERSANA THERAPEUTICS INC | $3,619,500 | – | 2,850,000 | +100.0% | 1.02% | – |
| New | AEGLEA BIOTHERAPEUTICS INC | $2,968,138 | – | 242,297 | +100.0% | 0.84% | – | |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $2,954,000 | – | 200,000 | +100.0% | 0.83% | – |
| New | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $2,850,000 | – | 50,000 | +100.0% | 0.80% | – | |
| ALKS | New | ALKERMES PLC | $2,801,000 | – | 100,000 | +100.0% | 0.79% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $2,632,157 | – | 60,426 | +100.0% | 0.74% | – |
| New | NUVALENT INC | $2,298,500 | – | 50,000 | +100.0% | 0.65% | – | |
| SGEN | New | SEAGEN INC | $2,121,500 | – | 10,000 | +100.0% | 0.60% | – |
| LNTH | New | LANTHEUS HLDGS INC | $2,084,400 | – | 30,000 | +100.0% | 0.59% | – |
| ACRS | New | ACLARIS THERAPEUTICS INCput | $1,781,000 | – | 260,000 | +100.0% | 0.50% | – |
| New | ROIVANT SCIENCES LTD | $1,752,000 | – | 150,000 | +100.0% | 0.49% | – | |
| TERN | New | TERNS PHARMACEUTICALS INC | $1,634,750 | – | 325,000 | +100.0% | 0.46% | – |
| INSP | New | INSPIRE MED SYS INC | $1,248,783 | – | 6,293 | +100.0% | 0.35% | – |
| EYPT | New | EYEPOINT PHARMACEUTICALS INCput | $1,238,450 | – | 155,000 | +100.0% | 0.35% | – |
| MORF | New | MORPHIC HLDG INCput | $1,145,500 | – | 50,000 | +100.0% | 0.32% | – |
| TVTX | New | TRAVERE THERAPEUTICS INC | $894,000 | – | 100,000 | +100.0% | 0.25% | – |
| PODD | New | INSULET CORP | $797,450 | – | 5,000 | +100.0% | 0.22% | – |
| New | BIOHAVEN LTD | $784,358 | – | 30,156 | +100.0% | 0.22% | – | |
| AVRO | New | AVROBIO INC | $770,000 | – | 500,000 | +100.0% | 0.22% | – |
| ETNB | New | 89BIO INCcall | $575,912 | – | 37,300 | +100.0% | 0.16% | – |
| New | PROMIS NEUROSCIENCES INC | $526,677 | – | 265,958 | +100.0% | 0.15% | – | |
| MESO | New | MESOBLAST LTDput | $492,000 | – | 400,000 | +100.0% | 0.14% | – |
| ARAV | New | ARAVIVE INC | $45,739 | – | 346,511 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MORPHIC HOLDING INC | 12 | Q3 2023 | 6.9% |
| KURA ONCOLOGY INC | 12 | Q3 2023 | 7.2% |
| CELLDEX THERAPEUTICS INC NEW | 12 | Q3 2023 | 1.9% |
| IMMATICS N.V | 12 | Q3 2023 | 0.4% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.4% |
| ESTABLISHMENT LABS HLDGS INC | 11 | Q3 2023 | 8.3% |
| VINCERX PHARMA INC | 11 | Q2 2023 | 4.5% |
| ASCENDIS PHARMA A/S | 11 | Q3 2023 | 4.9% |
| CYTOKINETICS INC | 11 | Q3 2023 | 2.6% |
| INARI MED INC | 10 | Q1 2023 | 6.4% |
View Affinity Asset Advisors, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 03, 2023 | 7,477,000 | 9.2% |
View Affinity Asset Advisors, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-21 |
| 13F-HR | 2023-08-14 |
| SC 13G | 2023-07-03 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-13 |
View Affinity Asset Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.